Advertisement · 728 × 90

Posts by Rob Brierley

Figure showing projected prevalence (cases, in billions) and age-standardised
prevalence rates (per 100 000 people) of MASLD from 1990 to 2050
The solid lines represent GBD 2023 estimates, while the dotted lines indicate
forecasted estimates beyond 2023. The shaded areas represent 95% uncertainty
intervals. GBD=Global Burden of Diseases, Injuries, and Risk Factors Study.
MASLD=metabolic dysfunction-associated steatotic liver disease. Copyright: 2026 Elsevier Ltd. All rights reserved.

Figure showing projected prevalence (cases, in billions) and age-standardised prevalence rates (per 100 000 people) of MASLD from 1990 to 2050 The solid lines represent GBD 2023 estimates, while the dotted lines indicate forecasted estimates beyond 2023. The shaded areas represent 95% uncertainty intervals. GBD=Global Burden of Diseases, Injuries, and Risk Factors Study. MASLD=metabolic dysfunction-associated steatotic liver disease. Copyright: 2026 Elsevier Ltd. All rights reserved.

Metabolic liver disease could affect nearly 1.8 billion people by 2050, suggests new #GBD study in @lancetgastrohep.bsky.social

Explore the research ▶️ spkl.io/63323ANwOT

1 week ago 5 5 0 0
Post image

The May issue of @lancetgastrohep.bsky.social is out now at www.thelancet.com/gastrohep!

Content this month includes #colorectalsurgery, #colorectalcancer, #viralhepatitis + more

#GastroSky #MedSky #LiverSky #HepSky

1 week ago 2 2 0 0
Promotional card announcing the launch of The Lancet Regional Health - Eastern Mediterranean. Text on card reads: Discover a new open access journal advancing clinical practice and health policy in the Eastern Mediterranean. Image depicts a woman sitting in a chair while speaking to a doctor holding an electronic tablet.

Promotional card announcing the launch of The Lancet Regional Health - Eastern Mediterranean. Text on card reads: Discover a new open access journal advancing clinical practice and health policy in the Eastern Mediterranean. Image depicts a woman sitting in a chair while speaking to a doctor holding an electronic tablet.

🆕 Introducing The Lancet Regional Health – Eastern Mediterranean, a new #goldopenaccess journal promoting the advancement of clinical practice and health policy in the Eastern Mediterranean.

Discover the new addition to The Lancet Group at: spkl.io/63328AFIyw #medsky

2 weeks ago 3 7 0 0
Preview
Robot-assisted versus conventional minimally invasive oesophagectomy for oesophageal squamous cell carcinoma (RAMIE): a multicentre, open-label, randomised, phase 3, non-inferiority trial In patients with resectable oesophageal squamous cell carcinoma, robot-assisted oesophagectomy was non-inferior, and seemed superior, to thoracoscopic oesophagectomy in terms of 5-year overall surviva...

🆕 Robot-assisted versus conventional minimally invasive oesophagectomy for oesophageal squamous cell carcinoma (RAMIE): a multicentre, open-label, randomised, phase 3, non-inferiority trial

www.thelancet.com/journals/lan...

#GastroSky #OncSky #SurgSky

3 weeks ago 1 1 0 0
Preview
Socioeconomic disparities in treatment and survival of oesophageal and gastric cancer in the Netherlands: a nationwide population-based study Despite universal health insurance, socioeconomic disparities in treatment and survival of gastroesophageal cancer patients persist in the Netherlands, reflecting not inequitable access but broader li...

Even with universal health insurance, inequalities persist.

A Dutch study of >30 000 gastroesophageal cancer patients shows lower-income groups are less likely to receive surgery or systemic therapy—and have poorer survival. @amsterdamumc.bsky.social www-tinyurl.com/a296ab1e

3 weeks ago 0 1 1 0
Clinical characteristics of primary sclerosing cholangitis. (A) The disease affects the biliary tree through inflammation and fibrosis, which results in multifocal biliary strictures and a high risk of cholangiocarcinoma. (B) When the disease progresses, high-grade strictures, often with prestenotic dilatation, can develop, leading to biliary obstruction and clinical symptoms. (C) Fatigue, itching, jaundice, bacterial cholangitis, and intermittent or persistent right upper-quadrant abdominal pain are common symptoms and signs in primary sclerosing cholangitis. Primary sclerosing cholangitis is associated with inflammatory bowel disease and 50–80% of affected individuals have concomitant inflammatory bowel disease. Primary sclerosing cholangitis inflammatory bowel disease shows distinct features from classic isolated inflammatory bowel disease, often with extensive colitis, a patchy inflammatory distribution that shows dominance of inflammation in the ascending colon, rectal sparing, and an increased risk of colorectal dysplasia compared with colitis without primary sclerosing cholangitis. (D) The inflammation almost always involves the colon and isolated ileal disease is rare. Reproduced with permission from Kari C Toverud.

Clinical characteristics of primary sclerosing cholangitis. (A) The disease affects the biliary tree through inflammation and fibrosis, which results in multifocal biliary strictures and a high risk of cholangiocarcinoma. (B) When the disease progresses, high-grade strictures, often with prestenotic dilatation, can develop, leading to biliary obstruction and clinical symptoms. (C) Fatigue, itching, jaundice, bacterial cholangitis, and intermittent or persistent right upper-quadrant abdominal pain are common symptoms and signs in primary sclerosing cholangitis. Primary sclerosing cholangitis is associated with inflammatory bowel disease and 50–80% of affected individuals have concomitant inflammatory bowel disease. Primary sclerosing cholangitis inflammatory bowel disease shows distinct features from classic isolated inflammatory bowel disease, often with extensive colitis, a patchy inflammatory distribution that shows dominance of inflammation in the ascending colon, rectal sparing, and an increased risk of colorectal dysplasia compared with colitis without primary sclerosing cholangitis. (D) The inflammation almost always involves the colon and isolated ileal disease is rare. Reproduced with permission from Kari C Toverud.

Primary sclerosing cholangitis is a rare liver disease, characterised by biliary inflammation and fibrosis.

A new Seminar explores the clinical features, pathogenesis, and challenges and opportunities in managing the disease: spkl.io/63326A0F5O

3 weeks ago 5 3 0 0
Post image

Read our April issue!

Featuring the global burden of lower respiratory tract infections, comparing test algorithms for syphilis, and chikungunya vaccination in adolescents.

bit.ly/4m1TuYb

3 weeks ago 6 8 1 2
Preview
The burden of chronic hepatitis B and C in 2022 and progress towards elimination: a global report Viral hepatitis represents a substantial burden of infectious disease globally, comparable with that caused by tuberculosis. Progress towards global hepatitis elimination is currently insufficient to ...

🆕 The burden of chronic hepatitis B and C in 2022 and progress towards elimination: a global report

www.thelancet.com/journals/lan...

#LiverSky #IDSky #HepSky #MedSky

3 weeks ago 11 5 0 1
Advertisement
Preview
Alcohol-Related Liver Disease May Be More Common Than We Think After adjusting for alcohol underreporting, prevalence doubled

Alcohol-Related Liver Disease May Be More Common Than We Think

www.medpagetoday.com/gastroentero... via @medpagetoday.com

#LiverSky #MedSky

3 weeks ago 0 1 0 0
Research in context panel for Lancet Gastroenterology & Hepatology paper entitled "Binge drinking, metabolic dysfunction, and the spectrum of steatotic liver disease in the USA: a cross-sectional and longitudinal analysis". Copyright:  2025 Elsevier Ltd. All rights are reserved.

Research in context panel for Lancet Gastroenterology & Hepatology paper entitled "Binge drinking, metabolic dysfunction, and the spectrum of steatotic liver disease in the USA: a cross-sectional and longitudinal analysis". Copyright: 2025 Elsevier Ltd. All rights are reserved.

Alcohol-related liver disease could be nearly three times higher than previous estimates, new US study suggests.

Find out more in @lancetgastrohep.bsky.social: spkl.io/63322A0liA

3 weeks ago 11 9 0 0
Preview
Binge drinking, metabolic dysfunction, and the spectrum of steatotic liver disease in the USA: a cross-sectional and longitudinal analysis Adjusting for alcohol underreporting reveals a higher burden of ALD and MetALD than was previously recognised. Type 2 diabetes and binge drinking were leading mortality risk factors. These findings un...

🆕 Binge drinking, metabolic dysfunction, and the spectrum of steatotic liver disease in the USA: a cross-sectional and longitudinal analysis

www.thelancet.com/journals/lan...

#LiverSky #MedSky #alcohol

4 weeks ago 0 1 1 0
Post image

Our April 2026 issue is live!

This themed issue on patient and public involvement in rheumatology includes priority setting partnerships, study co-design, and co-production of self-management tools and care pathways, plus much more! thelancet.com/journals/lan...
Cover by @emma-cheng.bsky.social

4 weeks ago 4 1 0 0
Post image

🆕Indocyanine green fluorescence angiography for anastomotic perfusion assessment in colorectal surgery: a systematic review with meta-analysis, meta-regression, and trial sequential analyses

www.thelancet.com/journals/lan...

#GastroSky #SurgSky #MedSky

4 weeks ago 0 1 0 0
Preview
The effect of alcohol minimum unit pricing and cancer warning labels on cancer incidence and mortality in Canada: an epidemiological modelling study Alcohol policies, particularly those combining pricing and labelling, could substantially reduce the cancer burden and health inequalities.

New The Lancet Public Health - The effect of alcohol minimum unit pricing and cancer warning labels on cancer incidence and mortality in Canada: an epidemiological modelling study

www.thelancet.com/journals/lan...

#GastroSky #MedSky #LiverSky

4 weeks ago 0 0 0 0
Post image

The April 2026 issue of @lancetgastrohep.bsky.social is out today at www.thelancet.com/gastrohep

This month's issue features content on #IBD, #cirrhosis, #pancreaticcancer, #viralhepatitis, #MASLD + more...

#GastroSky #MedSky #LiverSky

1 month ago 3 4 0 0
March cover of The Lancet Microbe

March cover of The Lancet Microbe

Our March issue is now online:

www.thelancet.com/journals/lan...

Our journal is #OpenAccess, so you are free to explore all of our content. But these hashtags offer a flavour: #malaria #HIV #Streptococcus #PCV #RiftValleyFever #pertussis #tuberculosis #TB #AMR

#IDSky #ClinMicro #TBSky #OA

1 month ago 4 6 1 1
Advertisement
Image: The first issue of The Lancet Regional Health Africa journal cover. Credit: David Sacks - Getty Images.

Image: The first issue of The Lancet Regional Health Africa journal cover. Credit: David Sacks - Getty Images.

🆕 Out now: the inaugural issue of The Lancet Regional Health – Africa, a Gold Open Access journal.

"As a journal, we stand for the decolonization of health and medical research in Africa."

Explore the full issue 👉 spkl.io/63320AIdt8

1 month ago 11 7 0 0
Post image

Just presented at #ECCO2026 - 10-year data from the LIR!C trial comparing ileocaecal resection vs infliximab for ileal Crohn’s disease

Now published in @lancetgastrohep.bsky.social

www.thelancet.com/journals/lan...

#ECCO26 #GastroSky #MedSky #IBDSky

2 months ago 0 1 0 0
Preview
Safety, pharmacokinetics, and preliminary efficacy of VS-01, an intraperitoneal liposomal infusion, in patients with decompensated liver cirrhosis, ascites, and covert hepatic encephalopathy: a phase ... VS-01 was generally well tolerated with a favourable safety profile in patients with decompensated liver cirrhosis, ascites, and covert hepatic encephalopathy. The results of this study supported the ...

New research - Safety, pharmacokinetics, and preliminary efficacy of VS-01, an intraperitoneal liposomal infusion, in patients with decompensated liver cirrhosis, ascites, and covert hepatic encephalopathy: a phase 1b study

www.thelancet.com/journals/lan...

#LiverSky #MedSky

2 months ago 1 1 0 0
Post image

Our March issue is now live at www.thelancet.com/gastrohep!

Content includes: #alcohol, #IBD, #HBV, #MASLD, #SIMD (#SIBO) + more!

#GastroSky #LiverSky #MedSky

2 months ago 2 3 0 0
Preview
Efimosfermin alfa (BOS-580) once per month in people with metabolic dysfunction-associated steatohepatitis with F2 or F3 fibrosis: results from a 24-week, randomised, double-blind, placebo-controlled,... In this phase 2 trial, treatment with efimosfermin once per month was generally well tolerated in participants with biopsy-confirmed MASH and F2 or F3 fibrosis. These results support the further devel...

New @thelancet.com - Efimosfermin alfa (BOS-580) once per month in people with MASH with F2 or F3 fibrosis: results from a 24-week, randomised, double-blind, placebo-controlled, phase 2 trial

www.thelancet.com/journals/lan...

#LiverSky #MedSky #EndoSky #GastroSky

2 months ago 1 2 0 0

New World Report in @thelancet.com examines the controversial trial of hepatitis B virus birth dose vaccination that was planned in Guinea-Bissau

#HepSky #LiverSky #IDSky

2 months ago 0 1 0 0
Announcing The Lancet Medical Imaging & Theranostics. A new open access journal dedicated to clinical and technological advances in radiology, neuclear medicine, and theranostics. Artwork: Abstract medical image of a torso with vibrant organic shapes and geometric patterns, suggesting medical imaging. Credit: Shonagh Rae

Announcing The Lancet Medical Imaging & Theranostics. A new open access journal dedicated to clinical and technological advances in radiology, neuclear medicine, and theranostics. Artwork: Abstract medical image of a torso with vibrant organic shapes and geometric patterns, suggesting medical imaging. Credit: Shonagh Rae

🚀 Just launched – our new #goldopenaccess journal on medical imaging and theranostics!
Learn more about the journal’s mission and explore related content from The Lancet Group today: hubs.li/Q041CgFF0

#medsky

2 months ago 7 13 0 0
Post image

New research: Long-term oncological outcomes following algorithm-based vs usual care for the early recognition & management of complications after pancreatic resection: post-hoc analysis of a stepped-wedge cluster-randomised trial

www.thelancet.com/journals/lan...

#GastroSky #OncSky #MedSky

2 months ago 0 1 0 0

EMA grants conditional marketing authorisation for semaglutide for treatment of non-cirrhotic MASH with liver fibrosis

#LiverSky #MedSky

2 months ago 1 0 0 0
Preview
NHS to increase accuracy of bowel cancer test in England Increased sensitivity of test that detects the second deadliest cancer will save hundreds of lives, oncologists say

NHS England to lower threshold for the amount of blood detected by FIT that triggers further investigation from 120 to 80 micrograms of blood/g of stool by 2028

www.theguardian.com/society/2026...

#GastroSky #MedSky #OncSky

2 months ago 1 0 0 0
Advertisement
Preview
Safety and efficacy of CRS3123 in adults with a primary episode or first recurrence of Clostridioides difficile infection: a phase 2, randomised, double-blind, multicentre, vancomycin-controlled study Both doses of CRS3123 were deemed safe and well tolerated and showed efficacy similar to vancomycin at the TOC visit, with lower rates of recurrence. Together, these data support further development o...

New Research

Safety and efficacy of CRS3123 in adults with a primary episode or first recurrence of Clostridioides difficile infection: a phase 2, randomised, double-blind, multicentre, vancomycin-controlled study

www.thelancet.com/journals/lan...

2 months ago 4 5 0 1
Preview
Guinea-Bissau Suspends Trump-Backed Hep B Vaccine Trial for Ethical Review But HHS spokesman says the study 'is proceeding as planned'

Guinea-Bissau Suspends Trump-Backed Hep B Vaccine Trial for Ethical Review www.medpagetoday.com/infectiousdi...

#LiverSky #IDSky #HepSky #MedSky

2 months ago 3 2 0 0
Post image

NEW RESEARCH—Long-term outcomes of abatacept in individuals at risk of developing rheumatoid arthritis (ALTO): a randomised, double-blind, placebo-controlled trial bit.ly/4pSERqq

Plus, linked Comment bit.ly/49v27Ga #Medsky #Rheumsky

3 months ago 0 2 0 0
Preview
ASCO Gastrointestinal Cancers Symposium 2026 A prespecified interim analysis of HERIZON-GEA-01 indicates that zanidatamab—a dual HER2-targeted monoclonal antibody that crosslinks neighbouring HER2 receptors and causes receptor clustering—might b...

News - ASCO Gastrointestinal Cancers Symposium 2026

www.thelancet.com/journals/lan...

#GI26 #ASCOGI #GastroSky #OncSky #MedSky

3 months ago 1 1 0 0